Keyphrases
Adjusted Hazard Ratio
25%
Angiotensin Receptor Blockers
25%
Angiotensin-converting Enzyme Inhibitor (ACEi)
37%
Aspirin
100%
Baseline Covariates
12%
Cardiac Ejection Fraction
25%
Clinical Significance
12%
Conditional Model
12%
Confidence Interval
25%
Cox Model
12%
Cyclooxygenase-1 (COX-1)
12%
Extended Cox Model
25%
First Hospitalization
12%
Heart Failure Death
12%
Heart Failure Events
62%
Heart Failure Hospitalization
37%
Heart Failure Patients
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
25%
Hospitalization
12%
Marginal Model
12%
No Significant Difference
25%
Patients with Heart Failure
25%
Randomized Trial
12%
Recurrent Event Analysis
12%
Time Marginals
12%
Warfarin
62%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
100%
Angiotensin Receptor Antagonist
22%
Congestive Heart Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Heart Failure with Reduced Ejection Fraction
22%
Prostaglandin Synthase
11%
Warfarin
55%
Nursing and Health Professions
Angiotensin Receptor Antagonist
22%
Confidence Interval
22%
Congestive Heart Failure
100%
Dipeptidyl Carboxypeptidase Inhibitor
33%
Hazard Ratio
22%
Heart Ejection Fraction
22%
Heart Failure with Reduced Ejection Fraction
22%
Proportional Hazards Model
33%
Prostaglandin Synthase
11%
Warfarin
55%